Antimicrobial Agents and Resistance
The Antimicrobial Agents and Resistance (AAR) track features the latest on the discovery and development of new antimicrobial drugs in the pipeline, and their associated resistance mechanisms. The AAR track focuses on a broad range of topics, including surveillance and global epidemiology, mechanisms of resistance, antimicrobial discovery from pre-clinical investigations to post-marketing data, stewardship, novel approaches to infection diagnosis and treatment, and pharmacokinetic/pharmacodynamic principles to optimize antimicrobial design and use.
Subtracks
Antimicrobial Agents and Resistance
-
AAR01
Surveillance of Antimicrobial Resistance: Molecular Typing, Clinical & Molecular Epidemiology
-
AAR02
Antibiotic Agents: Mechanisms of Action and Resistance
-
AAR03
Antifungal Agents: Mechanisms of Action and Resistance
-
AAR04
Antiviral Agents (including HIV Drugs): Mechanisms of Action and Resistance
-
AAR05
Antimicrobial Stewardship
-
AAR06
Novel Approaches: Diagnostics/Discovery and Non-Traditional Therapies to Combat Drug-Resistant Infections
-
AAR07
Antimicrobial Pharmacokinetics and Pharmacodynamics
-
AAR08
New Antimicrobial Agents (In Vitro and In Vivo Studies Prior to the Start of Clinical Therapeutic Studies/Pre-Phase 2)
-
AAR09
Pharmacological Studies of Antimicrobial Agents Pre-NDA (Phase 2/3)